LN04 - Lymphoma Tissue Microarray

Similar documents
CC01 - Colon Cancer Tissue Microarray

MT09 - Normal Human Tissue Microarray, FDA

ab Lymphoma tissue array of 102 cases (1.5mm) set 2

Ab T cell lymphoma tissue array, 75 cases, 150 samples (1.1mm), set 3

ab Lymphoma tissue array of 102 cases (1.5mm) set 1

ab Stomach cancer tissue array of 228 cases (1.1mm)

Multi-normal human tissues, FDA, 96 samples, 35 organs/sites from three individuals (1.5mm)

ab Colon cancer tissue array with progressive changes, 48 cases, 96 samples (1.5mm), set 1

H&E, IHC anti- Cytokeratin

ab Prostate cancer tissue array, 24 cases, 48 samples (1.5mm)

ab Thyroid cancer tissue array, 75 cases, 150 samples (1.1mm), set 1

ab Kidney cancer tissue array of 102 cases (1.5mm)

ab Head and neck tumor tissue array, 48 cases, 96 samples (1.5mm), set 1

ab Colon cancer tissue array of 228 cases (1.1mm)

Testis/ovary germ cell tumor tissue array, 48 cases, 96 samples

ab Nervous system tumor tissue array, 48 cases, 96 samples (1.5mm)

ab Tonsillitis tissue array 114 cases 228 samples (1.1mm)

ab Pancreatic cancer tissue array, 24 cases, 48 samples (2mm)

ab Nervous system tumor tissue array, 102 cases (1.5mm)

ab Melanoma (primary and metastatic) tissue array, 48 cases, 96 samples (1.5mm)

Nasopharyngeal primary and metastatic carcinoma tissue array, 96 samples (1.5mm), set 1

ab Nervous system glioma tissue array, 48 cases, 96 samples (1.5mm)

ab Lung cancer tissue array paired with normal tissues, 16 cases, 48 samples (2mm), set 2

ab Lung cancer tissue array, 75 cases, 150 samples (1.1mm), set 1

Breast cancer tissue array with progressive changes, 48 cases, 96 samples (1.5mm), set 1

ab Endometrial cancer tissue array of 102 cases (1.5mm)

ab Breast cancer tissue array with progressive changes, 48 cases, 96 samples (1.5mm), set 2

ab Endometrial cancer tissue array, 75 cases, 150 samples (1.1mm), set 1

ab Soft tissue tumor tissue array, 48 cases, 96 samples (1.5mm), set 1

ab Skin tumor tissue array, 75 cases, 150 samples (1.1mm)

ab Cervical cancer tissue array with progressive changes, 48 cases, 96 samples (1.5mm), set 2

Gastrointestinal stromal tumor (GIST) tissue array, 24 cases, 48 samples (2mm)

ab Ovary cancer tissue array of 102 cases (1.5mm)

ab Cervical cancer tissue array paired with normal tissue, 16 cases, 48 samples, (2mm).

ab Lung cancer tissue array with progressive changes, 48 cases, 96 samples (1.5mm), set 2

ab Head and neck tumor tissue array, 102 cases (1.5mm)

IMPC phenotyping SOPs in JMC

Cancer Program Report 2014

Cancer in Estonia 2014

Outcomes Report: Accountability Measures and Quality Improvements

Central Pathology Review and Tissue MicroArrays. Dr Lisa Storer Children s Brain Tumour Research Centre Nottingham

MCR: MANAGEMENT OF 2018 CHANGES. By: Maricarmen Traverso-Ortiz MPH, CGG, CTR

Neoplasms/Lymphoma/Leukemia

INTRODUCTION TO PATHOLOGICAL TECHNIQUES. 1. Types of routine biopsy procedures 2. Special exams (IHC, FISH)

Introduction to ICD-O-3 coding rules

TEST MENU BY SPECIALTY

CODING PRIMARY SITE. Nadya Dimitrova

Molecular Pathology of Lymphoma (Part 1) Rex K.H. Au-Yeung Department of Pathology, HKU

Understanding your diagnosis. Dr Graham Collins Consultant Haemtologist Oxford University Hospitals

Case: The patient is a 73 year old woman with vague complaints of dyspepsia and abdominal pain. Upper endoscopy showed features of gastritis and a

Comprehensive cancer cover

MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site

ANNUAL CANCER REGISTRY REPORT-2005

List of Available TMAs in the PRN

TRIPath FEE Schedule

S2 File. Clinical Classifications Software (CCS). The CCS is a

Comprehensive cancer cover

CS 6824: Tissue-Based Map of the Human Proteome

Macmillan Publications

Outcomes Report: Accountability Measures and Quality Improvements

Cancer Association of South Africa (CANSA)

ACHIEVING EXCELLENCE IN ABSTRACTING: LYMPHOMA

Patient underwent hemicolectomy: 7 x 4.5 cm intusscepted segment of ileum in colon - mucosal

Cancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC

A Probabilistic Approach for the Assessment of Internal Dose to Chronic Lymphocytic Leukemia Precursor Cells

NEOPLASIA-I CANCER. Nam Deuk Kim, Ph.D.

155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary

Cancer of lymph nodes survival rate

CEA (CARCINOEMBRYONIC ANTIGEN)

Single and Multiplex Immunohistochemistry

Epidemiology in Texas 2006 Annual Report. Cancer

Workshop Case # 8 (H 4205/07)

Contents. vii. Preface... Acknowledgments... v xiii

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:

PD-L1 Analyte Control DR

FINALIZED SEER SINQ S MAY 2012

Q: In order to use the code 8461/3 (serous surface papillary) for ovary, does it have to say the term "surface" on the path report?

Histopathological analysis of lymph nodes in patient with clinical lymphadenopathy cases

Quality in Control ALK-Lung Analyte Control (EML4-ALK) ALK-Lymphoma Analyte Control (NPM-ALK)

VDx: Unlocking Complex Diagnostics

The European Commission s science and knowledge service. Joint Research Centre

Presentation material is for education purposes only. All rights reserved URMC Radiology Page 1 of 98

Pearls and pitfalls in interpretation of lymphoid lesions in needle biopsies

objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University

IBD-Related Lymphoma

Corporate Medical Policy

BREAST PATHOLOGY GROSSING GUIDELINES

Abstract. Introduction. Salah Abobaker Ali

Two Cases of Primary Gastric Lymphoma, Mucosa-Associated Lymphoid Tissue (MALT)-type

Oncology General Principles L A U R I E S I M A R D B R E A S T S U R G I C A L O N C O L O G Y F E L L O W D E C E M B E R

SHN-1 Human Digestive Panel Test results

Physician On-line Staging Application. Darlene Dale Head, PMH Cancer Registry

HISTOPATHOLOGY. Introduction

SYLLABUS BDS I PROFESSIONAL GENERAL HUMAN ANATOMY INCLUDING EMBRYOLOGY AND HISTOLOGY

Cancer survival in Shanghai, China,

Dr. dr. Primariadewi R, SpPA(K)

11/8/2018 DISCLOSURES. I have NO Conflicts of Interest to Disclose. UTILTY OF DETECTING PATTERNS

Transcription:

Reveal Biosciences offers Histochemical Staining, Immunohistochemistry (IHC), In Situ Hybridization (ISH), Whole Slide Imaging, and Quantitative Image Analysis on any TMA LN04 - Lymphoma Tissue Microarray A B C D E F G H I J 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Cases: 75 Cores: 150 Core Size: 1.1mm Core Thickness: 4um Format: 10 x 15 QA/QC: H&E, IHC anti-cytokeratin Normal Benign Malignant Orientation core Description: Lymphoma tissue array, 150 cores from reactive lymphoid tissues (5 cases) and various lymphoma (70 cases) tissues in duplicates. All tissues were fixed in 10% neutral buffer formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. All TMAs are cut fresh upon ordering. They all have a guaranteed six month shelf-life at 4 degrees Celsius from the date of shipment. Additional cores not listed are orientation markers and have no data. There may be <5% core loss per slide but the core retention rate should be >90%. Note: Bake at 60 C for 30 minutes before use.

A01 M 26.0 Lymph node Reactive A02 M 47.0 Lymph node Reactive A03 M 31.0 Tonsil Reactive A04 M 14.0 Tonsil Reactive A05 F 21.0 Spleen Normal A06 F 77.0 Thyroid MALT B cell lymphoma A07 M 62.0 Stomach Non-Hodgkin lymphoma A08 M 50.0 Intestine, Non-Hodgkin B cell lymphoma A09 M 41.0 Lymph node, Hodgkin lymphoma A10 M 55.0 Lymph node, Peripheral T cell lymphoma, A11 M 54.0 Shoulder Non-Hodgkin B cell lymphoma A12 M 39.0 Lymph node, Non-Hodgkin B cell lymphoma A13 M 5.0 Lymph node Anaplastic large cell lymphoma? A14 M 40.0 Lymph node Hodgkin lymphoma A15 M 48.0 Intestine, Non-Hodgkin B cell lymphoma B01 M 26.0 Lymph node Reactive B02 M 47.0 Lymph node Reactive B03 M 31.0 Tonsil Reactive B04 M 14.0 Tonsil Reactive B05 F 21.0 Spleen Normal B06 F 77.0 Thyroid MALT B cell lymphoma B07 M 62.0 Stomach Non-Hodgkin lymphoma B08 M 50.0 Intestine, Non-Hodgkin B cell lymphoma B09 M 41.0 Lymph node, Hodgkin lymphoma B10 M 55.0 Lymph node, Peripheral T cell lymphoma, B11 M 54.0 Shoulder Non-Hodgkin B cell lymphoma B12 M 39.0 Lymph node, Non-Hodgkin B cell lymphoma B13 M 5.0 Lymph node Anaplastic large cell lymphoma? B14 M 40.0 Lymph node Hodgkin lymphoma B15 M 48.0 Intestine, Non-Hodgkin B cell lymphoma C01 M 60.0 Intestine, Lymphoma, diffuse large B cell C02 M 42.0 Axillary lymph Non-Hodgkin B cell lymphoma C03 M 7.0 Lymph node Hodgkin lymphoma

Pos. Sex Age Anatomic Site Pathology Grad Stage (TNM) C04 M 66.0 Lymph node Non-Hodgkin lymphoma C05 M 40.0 Intestine, Lymphoma, non-hodgkin B cell C06 M 33.0 Lymph node, Non-Hodgkin B cell lymphoma C07 M 53.0 Lymph node, Anaplastic large cell lymphoma? C08 F 32.0 Lung lymph Non-Hodgkin B cell lymphoma? C09 M 72.0 Testis Non-Hodgkin B cell lymphoma C10 F 71.0 Lymph node Non-Hodgkin B cell lymphoma C11 M 43.0 Stomach MALT B cell lymphoma, high grade C12 F 52.0 Lymph node, Diffuse large B cell lymphoma C13 M 60.0 Intestine, colon MALT B cell lymphoma? C14 M 30.0 Peritoneal Hodgkin lymphoma C15 F 40.0 Peritoneal Non-Hodgkin B cell lymphoma D01 M 60.0 Intestine, colon Lymphoma, diffuse large B cell D02 M 42.0 Axillary lymph Non-Hodgkin B cell lymphoma D03 M 7.0 Lymph node Hodgkin lymphoma D04 M 66.0 Lymph node Non-Hodgkin lymphoma D05 M 40.0 Intestine, Lymphoma, non-hodgkin B cell D06 M 33.0 Lymph node, Non-Hodgkin B cell lymphoma D07 M 53.0 Lymph node, Anaplastic large cell lymphoma? D08 F 32.0 Lung lymph Non-Hodgkin B cell lymphoma? D09 M 72.0 Testis Non-Hodgkin B cell lymphoma D10 F 71.0 Lymph node Non-Hodgkin B cell lymphoma D11 M 43.0 Stomach MALT B cell lymphoma, high grade D12 F 52.0 Lymph node, Diffuse large B cell lymphoma D13 M 60.0 Intestine, colon MALT B cell lymphoma? D14 M 30.0 Peritoneal Hodgkin lymphoma D15 F 40.0 Peritoneal Non-Hodgkin B cell lymphoma E01 F 33.0 Stomach MALT B cell lymphoma, high grade E02 F 70.0 Lymph node, Non-Hodgkin B cell lymphoma E03 F 43.0 Lymph node, Non-Hodgkin B cell lymphoma E04 M 65.0 Lymph node Non-Hodgkin B cell lymphoma E05 M 76.0 Tonsil Diffuse large B cell lymphoma E06 F 32.0 Pelvic Cavity Non-Hodgkin B cell lymphoma

E07 M 39.0 Lymph node, Non-Hodgkin B cell lymphoma E08 M 50.0 Lymph node, Hodgkin lymphoma E09 M 43.0 Intestine, ilium Lymphoma, diffuse large B cell E10 F 53.0 Lymph node, Mantle cell lymphoma E11 F 72.0 Lymph node Non-Hodgkin B cell lymphoma E12 M 53.0 Lymph node, Diffuse large B cell lymphoma E13 F 55.0 Lymph node, Non-Hodgkin lymphoma E14 F 55.0 Breast Lymphoma, diffuse large B cell E15 M 13.0 Shoulder Diffuse large B cell lymphoma F01 F 33.0 Stomach MALT B cell lymphoma, high grade F02 F 70.0 Lymph node, Non-Hodgkin B cell lymphoma F03 F 43.0 Lymph node, Non-Hodgkin B cell lymphoma F04 M 65.0 Lymph node Non-Hodgkin B cell lymphoma F05 M 76.0 Tonsil Diffuse large B cell lymphoma F06 F 32.0 Pelvic Cavity Non-Hodgkin B cell lymphoma F07 M 39.0 Lymph node, Non-Hodgkin B cell lymphoma F08 M 50.0 Lymph node, Hodgkin lymphoma F09 M 43.0 Intestine, ilium Lymphoma, diffuse large B cell F10 F 53.0 Lymph node, Mantle cell lymphoma F11 F 72.0 Lymph node Non-Hodgkin B cell lymphoma F12 M 53.0 Lymph node, Diffuse large B cell lymphoma F13 F 55.0 Lymph node, Non-Hodgkin lymphoma F14 F 55.0 Breast Lymphoma, diffuse large B cell F15 M 13.0 Shoulder Diffuse large B cell lymphoma G01 M 35.0 Lymph node Non-Hodgkin B cell lymphoma G02 M 40.0 Tonsil Non-Hodgkin B cell lymphoma G03 F 54.0 Lymph node Hodgkin lymphoma G04 M 24.0 Intestine, ilium- Non-Hodgkin B cell lymphoma G05 M 64.0 Lymph node Non-Hodgkin B cell lymphoma G06 M 49.0 Lymph node, Hodgkin lymphoma G07 M 65.0 Stomach MALT B cell lymphoma, high grade G08 M 73.0 Kidney Lymphoma, diffuse large B cell G09 M 4.0 Lymph node, Non-Hodgkin B cell lymphoma

G10 F 70.0 Intestine, ilium Lymphoma, diffuse large B cell G11 F 52.0 Lung Non-Hodgkin lymphoma G12 M 51.0 Stomach Non-Hodgkin B cell lymphoma G13 M 28.0 Intestine, ileum Lymphoma, diffuse large B cell G14 F 58.0 Stomach MALT B cell lymphoma, high grade G15 M 38.0 Lymph node Non-Hodgkin B cell lymphoma H01 M 35.0 Lymph node Non-Hodgkin B cell lymphoma H02 M 40.0 Tonsil Non-Hodgkin B cell lymphoma H03 F 54.0 Lymph node Hodgkin lymphoma H04 M 24.0 Intestine, ilium- Non-Hodgkin B cell lymphoma H05 M 64.0 Lymph node Non-Hodgkin B cell lymphoma H06 M 49.0 Lymph node, Hodgkin lymphoma H07 M 65.0 Stomach MALT B cell lymphoma, high grade H08 M 73.0 Kidney Lymphoma, diffuse large B cell H09 M 4.0 Lymph node, Non-Hodgkin B cell lymphoma H10 F 70.0 Intestine, ilium Lymphoma, diffuse large B cell H11 F 52.0 Lung Non-Hodgkin lymphoma H12 M 51.0 Stomach Non-Hodgkin B cell lymphoma H13 M 28.0 Intestine, ileum Lymphoma, diffuse large B cell H14 F 58.0 Stomach MALT B cell lymphoma, high grade H15 M 38.0 Lymph node Non-Hodgkin B cell lymphoma I01 F 58.0 Stomach MALT B cell lymphoma, high grade I02 M 67.0 Lymph node Non-Hodgkin lymphoma I03 F 53.0 Stomach MALT B cell lymphoma, high grade I04 M 73.0 Lymph node Hodgkin lymphoma I05 M 17.0 Intestine, small Non-Hodgkin B cell lymphoma I06 M 43.0 Brain Non-Hodgkin B cell lymphoma I07 M 43.0 Lymph node, Non-Hodgkin B cell lymphoma I08 M 76.0 Lymph node, Non-Hodgkin B cell lymphoma I09 F 51.0 Lymph node, Hodgkin lymphoma I10 F 74.0 Lymph node, Non-Hodgkin lymphoma I11 M 57.0 Lymph node, Hodgkin lymphoma I12 F 42.0 Breast Non-Hodgkin B cell lymphoma

I13 M 54.0 Lymph node, Hodgkin lymphoma I14 F 13.0 Lymph node, Hodgkin lymphoma I15 M 31.0 Peritoneal Anaplastic large cell lymphoma J01 F 58.0 Stomach MALT B cell lymphoma, high grade J02 M 67.0 Lymph node Non-Hodgkin lymphoma J03 F 53.0 Stomach MALT B cell lymphoma, high grade J04 M 73.0 Lymph node Hodgkin lymphoma J05 M 17.0 Intestine, small Non-Hodgkin B cell lymphoma J06 M 43.0 Brain Non-Hodgkin B cell lymphoma J07 M 43.0 Lymph node, Non-Hodgkin B cell lymphoma J08 M 76.0 Lymph node, Non-Hodgkin B cell lymphoma J09 F 51.0 Lymph node, Hodgkin lymphoma J10 F 74.0 Lymph node, Non-Hodgkin lymphoma J11 M 57.0 Lymph node, Hodgkin lymphoma J12 F 42.0 Breast Non-Hodgkin B cell lymphoma J13 M 54.0 Lymph node, Hodgkin lymphoma J14 F 13.0 Lymph node, Hodgkin lymphoma J15 M 31.0 Peritoneal Anaplastic large cell lymphoma